Skip to main content

Csenge Advisory Group

SEC CIK
0001715593
Latest filing
Aug 10, 2026

PMCB holding history

PharmaCyte Biotech, Inc. in every 13F filed by Csenge Advisory Group, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

PMCB overviewAll 13F holders of PMCBFull Q2 2026 holdings

Shares (Q4 2022)
0
Sold out in Q4 2022
Value
$0
% of portfolio
0.0%
Quarters held
1
Since Q3 2022
Holdings of PMCB by Csenge Advisory Group, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q4 20220$00.0%−200,104−100.0%Sold outHolders
Q3 2022200,104$480.0K<0.1%+200,104NewHolders